AU2005904615A0 - Reducing cardiac damage and arrhythmia susceptibility arising from loss, reduction or interruption in coronary arterial blood flow - Google Patents

Reducing cardiac damage and arrhythmia susceptibility arising from loss, reduction or interruption in coronary arterial blood flow

Info

Publication number
AU2005904615A0
AU2005904615A0 AU2005904615A AU2005904615A AU2005904615A0 AU 2005904615 A0 AU2005904615 A0 AU 2005904615A0 AU 2005904615 A AU2005904615 A AU 2005904615A AU 2005904615 A AU2005904615 A AU 2005904615A AU 2005904615 A0 AU2005904615 A0 AU 2005904615A0
Authority
AU
Australia
Prior art keywords
arising
interruption
loss
reduction
blood flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005904615A
Inventor
Steven Michael Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2005904615A0 publication Critical patent/AU2005904615A0/en
Priority to US12/064,077 priority Critical patent/US9629817B2/en
Priority to CA002661448A priority patent/CA2661448A1/en
Priority to PCT/AU2006/001207 priority patent/WO2007022568A1/en
Priority to AU2006284513A priority patent/AU2006284513B2/en
Priority to EP06774840.0A priority patent/EP1924326B1/en
Priority to US15/465,599 priority patent/US20170252308A1/en
Abandoned legal-status Critical Current

Links

AU2005904615A 2005-08-25 2005-08-25 Reducing cardiac damage and arrhythmia susceptibility arising from loss, reduction or interruption in coronary arterial blood flow Abandoned AU2005904615A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US12/064,077 US9629817B2 (en) 2005-08-25 2006-08-24 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
CA002661448A CA2661448A1 (en) 2005-08-25 2006-08-24 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
PCT/AU2006/001207 WO2007022568A1 (en) 2005-08-25 2006-08-24 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
AU2006284513A AU2006284513B2 (en) 2005-08-25 2006-08-24 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
EP06774840.0A EP1924326B1 (en) 2005-08-25 2006-08-24 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
US15/465,599 US20170252308A1 (en) 2005-08-25 2017-03-22 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow

Publications (1)

Publication Number Publication Date
AU2005904615A0 true AU2005904615A0 (en) 2005-09-08

Family

ID=

Similar Documents

Publication Publication Date Title
EP1853158B8 (en) Balanced physiological monitoring and treatment system
EP2061531A4 (en) Intravascular blood pump and catheter
EP2068768A4 (en) Method and system for improving diastolic function of the heart
EP1745808A4 (en) Medical filter material and, utilizing the same, extracorporeal circulation column and blood filter
IL212396A (en) 6-oxo-1,6-dihydropyridazines and use thereof in the manufacture of medicaments
AU2003221906A1 (en) Perfusion guidewire in combination with a distal filter
PL2399990T3 (en) Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system
IL174269A0 (en) Vascular access preservation in hemodialysis patients
HK1084845A1 (en) Managing and processing self-monitoring blood glucose
ZA200703697B (en) Use of ranolazone in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
SI2324871T1 (en) Citrate anticoagulation system for extracorporeal blood treatments
EP1970002A4 (en) Blood pressure meter cuff and blood pressure meter with the same
IL186118A0 (en) 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta- hydroxysteroid dehydrogenase
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
EP1924326A4 (en) Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
AU2003214725A1 (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
EP1707104A4 (en) Endoscope, endoscope system, and filter unit
EP1765832B8 (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
HK1121083A1 (en) Methods for reducing blood pressure
IL166794A0 (en) Harvester accumulator and basket structure
GB0516399D0 (en) Inherited transactions in asynchronous messaging
EP2214634A4 (en) Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter
WO2007106369A3 (en) Case-finding systems and methods
EP1952833A4 (en) Blood storage tank of closed type and extracorporeal blood circulation system using the same
AU2005904615A0 (en) Reducing cardiac damage and arrhythmia susceptibility arising from loss, reduction or interruption in coronary arterial blood flow